29615677|t|Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study.
29615677|a|We aimed to compare the longitudinal outcome of amnestic mild cognitive impairment (aMCI) patients with significant Pittsburgh Compound B uptake [PiB(+) aMCI] and those without [PiB(-) aMCI]. Cerebral beta-amyloid was measured in 47 patients with aMCI using PiB-positron emission tomography (PET) (31 PiB(+) aMCI and 16 PiB(-) aMCI). Clinical (N = 47) and neuropsychological follow-up (N = 37), and follow-up with brain magnetic resonance imaging (N = 38) and PiB-PET (N = 30) were performed for three years. PiB(+) aMCI had a higher risk of progression to dementia (hazard ratio = 3.74, 95% CI = 1.21-11.58) and faster rate of cortical thinning in the bilateral precuneus and right medial and lateral temporal cortices compared to PiB(-) aMCI. Among six PiB(-) aMCI patients who had regional PiB uptake ratio >1.5 in the posterior cingulate cortex (PCC), three (50.0%) progressed to dementia, and two of them had global PiB uptake ratio >1.5 at the follow-up PiB-PET. Our findings suggest that amyloid imaging is important for predicting the prognosis of aMCI patients, and that it is necessary to pay more attention to PiB(-) aMCI with increased regional PiB uptake in the PCC.
29615677	72	93	cognitive impairments	Disease	MESH:D003072
29615677	176	210	amnestic mild cognitive impairment	Disease	MESH:D060825
29615677	212	216	aMCI	Disease	MESH:D060825
29615677	218	226	patients	Species	9606
29615677	244	265	Pittsburgh Compound B	Chemical	MESH:C475519
29615677	274	277	PiB	Chemical	MESH:C069442
29615677	281	285	aMCI	Disease	MESH:D060825
29615677	306	309	PiB	Chemical	MESH:C069442
29615677	313	317	aMCI	Disease	MESH:D060825
29615677	361	369	patients	Species	9606
29615677	375	379	aMCI	Disease	MESH:D060825
29615677	386	389	PiB	Chemical	MESH:C069442
29615677	429	432	PiB	Chemical	MESH:C069442
29615677	436	440	aMCI	Disease	MESH:D060825
29615677	448	451	PiB	Chemical	MESH:C069442
29615677	455	459	aMCI	Disease	MESH:D060825
29615677	588	591	PiB	Chemical	MESH:C069442
29615677	644	648	aMCI	Disease	MESH:D060825
29615677	685	693	dementia	Disease	MESH:D003704
29615677	860	863	PiB	Chemical	MESH:C069442
29615677	867	871	aMCI	Disease	MESH:D060825
29615677	883	886	PiB	Chemical	MESH:C069442
29615677	890	894	aMCI	Disease	MESH:D060825
29615677	895	903	patients	Species	9606
29615677	921	924	PiB	Chemical	MESH:C069442
29615677	1012	1020	dementia	Disease	MESH:D003704
29615677	1049	1052	PiB	Chemical	MESH:C069442
29615677	1088	1091	PiB	Chemical	MESH:C069442
29615677	1123	1130	amyloid	Disease	MESH:C000718787
29615677	1184	1188	aMCI	Disease	MESH:D060825
29615677	1189	1197	patients	Species	9606
29615677	1249	1252	PiB	Chemical	MESH:C069442
29615677	1256	1260	aMCI	Disease	MESH:D060825
29615677	1285	1288	PiB	Chemical	MESH:C069442
29615677	Positive_Correlation	MESH:C069442	MESH:D003704
29615677	Positive_Correlation	MESH:C069442	MESH:D060825
29615677	Association	MESH:C475519	MESH:D060825
29615677	Association	MESH:C069442	MESH:C475519

